Expression of cytochrome P-450 4 enzymes in the kidney and liver: Regulation by PPAR and species-difference between rat and human

Molecular and Cellular Biochemistry

Volumn 284, Issue 1-2, 2006, Pages 141-148

  Ito, Osamu ^a   Nakamura, Yasuhiro ^a   Tan, Liping ^a   Ishizuka, Tsuneo ^a   Sasaki, Yuko ^a   Minami, Naoyoshi ^a   Kanazawa, Masayuki ^a   Ito, Sadayoshi ^a   Sasano, Hironobu ^a   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CYP4 family; Fatty acids; PPAR; Renal tubules; The hydroxylation

Indexed keywords

CLOFIBRATE; CYTOCHROME P450; CYTOCHROME P450 4A; CYTOCHROME P450 4F; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ALKANE 1 MONOOXYGENASE; CYP4F3 PROTEIN, HUMAN; HYDROXYICOSATETRAENOIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY HOMOGENATE; KIDNEY PROXIMAL TUBULE; LIVER CELL; LIVER HOMOGENATE; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SPECIES DIFFERENCE; ANIMAL; BIOSYNTHESIS; DRUG POTENTIATION; ENZYMOLOGY; HISTOLOGY; KIDNEY; LIVER; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ALKANE 1-MONOOXYGENASE; ANIMALS; CLOFIBRATE; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; THIAZOLIDINEDIONES;

EID: 33745929043     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9038-x     Document Type: Article

References (34)

1. Singh I: Biochemistry of peroxisomes in health and disease. Mol Cell Biochem 167: 1-29, 1997
2. Roman RJ: P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002
3. Aldridge TC, Tugwood JD, Green S: Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J 306: 473-479, 1995
4. Muerhoff AS, Griffin KJ, Johnson EF: The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J Biol Chem 267: 19051-19053, 1992
5. Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA, Desvergne B: DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. J Biol Chem 272: 25252-25259, 1997
6. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 94: 4312-4317, 1997
7. Green S: PPAR: A mediator of peroxisome proliferator action. Mutat Res 333: 101-109, 1995
8. Hardwick JP, Song BJ, Huberman E, Gonzalez FJ: Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. J Biol Chem 262: 801-810, 1987
9. Sundseth SS, Waxman DJ: Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J Biol Chem 267: 3915-3921, 1992
10. Gibson GC: Comparative aspects of the mammalian cytochrome P-450 IVA gene family. Xenobiotica 19: 1123-1148, 1989
11. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, Proia AD: Etomoxir induced PPARα-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278: F667-F675, 2000
12. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62: 367-379, 1988
13. Lehman J, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA: An antidiabetic thiazolidine is a high affinity ligand for peroxisome proliferator-activated receptorγ (PPARγ). J Biol Chem 270: 12953-12956, 1995
14. Pershadsingh HA, Szollosi J, Benson S, Hyun WC, Feuerstein BG, Kurtz TW: Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 21: 1020-1023, 1993
15. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H: Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 42: 75-80, 1993
16. Verma S, Bhanot S, Arakawa E, Yao L, Mcneill JH: Direct vasodepressor effects of pioglitazone in spontaneously hypertensive rats. Pharmacology 56: 7-16, 1998
17. Dubey RK, Zhang HY, Reddy SR, Boegehold MA, Kotchen TA: Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol 265: R726-R732, 1993
18. Yoshimoto T, Naruse M, Nishikawa M, Narusa K, Tanabe A, Seki T, Imaki T, Demura R, Aikawa E, Demura H: Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats. Am J Physiol 272: E989-E996, 1997
19. Ma LJ, Marcantoni C, Lifton MF, Fazio S, Fago AB: Peroxisome proliferator-activated receptor-gammma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59: 1899-1910, 2001
20. Omata K, Abraham NG, Schwartzman ML: Renal cytochrome P-450 arachidonic acid metabolism: Localization and hormonal regulation in SHR. Am J Physiol 262: F591-F599, 1992
21. Ito O, Alonso-Galicia M, Hopp KA, Roman RJ: Localization of cytochrome P450 4A isoforms along the rat nephron. Am J Physiol 274: F395-F404, 1998
22. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996
23. Guan Y, Zhang Y, Davis L, Breyer MD: Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am J Physiol 273: F1013-F1022, 1997
24. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC, Schnerman JB, Briggs JP: Expression of peroxisomal proliferator activated receptors and retinoid X receptors in the kidney. Am J Physiol 277: F966-F973, 1999
25. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK: Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. J Biol Chem 275: 4118-4126, 2000
26. Powell PK, Wolf I, Jin R, Lasker JM: Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285: 1327-1336, 1998
27. Kimura S, Hardwick JP, Kozak CA, Gonzalez FJ: The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8: 517-525, 1989
28. Imaoka S, Yamazoe Y, Kato R, Funae Y: Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary. Arch Biochem Biophys 299: 179-184, 1992
29. Savas U, Hsu MH, Johnson EF: Differntial regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch Biochem Biophys 409: 212-220, 2003
30. Bellamie A, Wang Y, Waterman MR, Gainer JV, Dawson EP, Brown NJ, Capdevila JH: Characterization of the CYP4A11 gene, a second CYP4A gene in human. Arch Biochem Biophys 409: 221-227, 2003
31. Kikuta Y, Kusunose E, Kusunose M: Prostaglandin and leukotriene ω-hydroxylases. Prostaglandins Other Lipid Mediat 68-69: 345-362, 2002
32. Stark K, Torma H, Cristea M, Oliw EH: Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch Biochem Biophys 409: 188-196, 2003
33. Laffer CL, Schwartzman ML, Wang MH, Nasjletti A, Elijovich F: Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation 107: 574-578, 2003
34. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD: Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110: 438-443, 2004